Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCS.L Share News (MCS)

  • There is currently no data for MCS

Wednesday broker round-up

Wed, 15th Jul 2020 12:24
(Sharecast News) - Royal Dutch Shell: JP Morgan downgrades to neutral with a target price of 1,700.0p.



Ocado Group: Berenberg reiterates buy with a target price of 2,225.0p.

DFS: Berenberg reiterates buy with a target price of 210.0p.

Atalaya Mining: Canaccord reiterates buy with a target price of 220.0p.

McCarthy & Stone: Canaccord reiterates hold with a target price of 82.0p.

Ferrexpo: JP Morgan downgrades to underweight with a target price of 150.0p.

GlaxoSmithKline: Citigroup reiterates neutral.

Auto Trader Group: Deutsche Bank reiterates buy with a target price of 680.0p.

London Stock Exchange: Deutsche Bank reiterates hold with a target price of 7,700.0p.

Legal & General Group: Deutsche Bank reiterates buy with a target price of 290.0p.

Senior: Barclays reiterates underweight with a target price of 45.0p.

Marks & Spencer Group: Barclays reiterates overweight with a target price of 140.0p.

Fevertree Drinks: Liberum reiterates buy with a target price of 2,570.0p.

Big Yellow Group: Liberum reiterates hold with a target price of 1,000.0p.

Dunelm Group: Peel Hunt reiterates buy with a target price of 1,400.0p.

Related News

LONDON BRIEFING: GSK hails cancer trial success; Plus500 backs outlook
1 hour ago

LONDON BRIEFING: GSK hails cancer trial success; Plus500 backs outlook

(Alliance News) - GSK reports positive Jemperli trial data, while Plus500 posts record first-half revenue. Elsewhere, Heathrow's first-half passenger ...

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
2 days ago

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial

* GSK partner Hansoh reports first late-stage data ​for experimental ⁠lung cancer drug

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
2 days ago

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial

(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...

MCS.L News

Housebuilders are too cheap, Jefferies says
19 Mar 2020

Housebuilders are too cheap, Jefferies says

(Sharecast News) - UK housebuilders are too cheap, Jefferies said as the broker placed 'buy' ratings on almost all sector stocks after big share price...

UK BROKER RATINGS SUMMARY: Jefferies Ups Taylor Wimpey, Barratt To Buy
19 Mar 2020

UK BROKER RATINGS SUMMARY: Jefferies Ups Taylor Wimpey, Barratt To Buy

UK BROKER RATINGS SUMMARY: Jefferies Ups Taylor Wimpey, Barratt To Buy

UK Shareholder Meetings Calendar - Next 7 Days
18 Mar 2020

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

McCarthy & Stone scraps dividend due to outbreak
18 Mar 2020

McCarthy & Stone scraps dividend due to outbreak

(Sharecast News) - Retirement housebuilder McCarthy & Stone said on Wednesday that the coronavirus would have a "material" impact on trading in th...

Retirement Housebuilder McCarthy & Stone Suspends Dividend Amid Virus
18 Mar 2020

Retirement Housebuilder McCarthy & Stone Suspends Dividend Amid Virus

Retirement Housebuilder McCarthy & Stone Suspends Dividend Amid Virus

UK Dividends Calendar - Next 7 Days
27 Feb 2020

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

UK BROKER RATINGS SUMMARY: HSBC Downgrades National Grid To Hold
20 Feb 2020

UK BROKER RATINGS SUMMARY: HSBC Downgrades National Grid To Hold

UK BROKER RATINGS SUMMARY: HSBC Downgrades National Grid To Hold

Friday broker round-up
7 Feb 2020

Friday broker round-up

(Sharecast News) - Vodafone: Jefferies upgrades to buy with a target price of 146p.